Search

everythinglearnresearchcommunity

for

Search:↓

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Microneedles are a promising method for drug delivery, offering efficient and convenient alternatives with fewer side effects.

Acyclovir cream may slow down hair growth, suggesting it could be a new treatment for excessive hairiness.

Calcipotriol plus betamethasone with microneedling works better than tacrolimus for treating vitiligo.

A drug called cimetidine can help treat hair loss in women by blocking androgen receptors. However, it's not the first choice and needs more research.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

A new compound shows promise as a topical treatment for hair loss.

Zebrafish helped find new ways to prevent drug-induced hair cell death and potential treatments for hearing loss.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Invasomes loaded with clotrimazole gel could improve drug delivery through the skin for fungal treatment.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

New treatments like nanotechnology show promise in improving skin cancer therapy.

The treatment with an oral drug and topical lotion is effective and well-tolerated for hair loss after COVID-19.

Hair loss causes emotional distress, leading to high spending on treatments, with Minoxidil and Propecia being common but having side effects.

The document concludes that proper diagnosis and treatment of follicular disorders are crucial, with specific treatments for conditions like acne, drug-induced eruptions, and rosacea.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

New drug targets for hair loss treatment were identified by studying cell interactions in hair follicles.

The research identified genes linked to male-pattern baldness and potential drug targets for treatment.

The new CoQ10 gel protects mouse skin better against aging from UV light than the old gel.

New gel formulas without ethanol and propylene glycol, containing a minoxidil-methyl-β-cyclodextrin complex, have been created for treating hair loss.

The document concludes that more research is needed to create specific drugs for treating male pattern baldness.

Some hair loss from medication may reverse after stopping the drug, but treatment options are limited and ongoing research is needed.